KilgourMD Secures Series A Funding
KilgourMD, a company known for its dermatologist-developed hair growth products that aim to reduce hair fall and stimulate hair follicle growth, has announced the closing of its Series A funding round. The funding, led by Prelude Growth Partners, was completed on March 26, 2026, and involves an undisclosed amount. Other participating investors include Willow Growth, Joyance Partners, and Able Partners.
Company Background
Founded in 2023 by Stanford-trained dermatologist Dr. James Kilgour, KilgourMD focuses on developing science-backed solutions for scalp health and hair regrowth. The company's products claim to reduce hair fall by 30% within two months and increase hair follicle growth by 200%, all without known side effects. Dr. Kilgour, who also serves as the CEO, developed these solutions inspired by personal experiences and professional observations of hair loss, particularly during menopause.
"KilgourMD was born out of seeing firsthand the experience of my mother, as well as countless patients, struggling with hair loss during menopause," Dr. Kilgour stated.
Board and Leadership Changes
The funding round brings changes to KilgourMD's board, with Alicia Sontag, Managing Partner at Prelude Growth Partners, joining the board alongside Dr. Kilgour. Other board members include Deborah Benton, Managing Partner at Willow Growth, and Dr. Alok Prasad, the company's COO.
Strategic Use of Funds
KilgourMD plans to utilize the Series A proceeds to expand its proprietary active ingredient pipeline. The company is also set to develop new product formulations and conduct clinical trials targeting underserved populations experiencing hair loss. The recent successful clinical trial, which focused on menopausal women, showed that 95% of participants experienced decreased hair shedding within six weeks, with the majority achieving significant regrowth by four months.
Market Position and Future Directions
KilgourMD is positioned at the intersection of clinical dermatology and consumer hair care, focusing on scalp aging as a root cause of hair thinning. The company offers a range of treatment and prevention products, including serums, shampoos, and conditioners. With a growing customer base, KilgourMD reports selling a bottle of its scalp serum every 20 seconds, highlighting its increasing popularity and market demand.
As KilgourMD continues to grow, its commitment to advancing scalp health and hair regrowth remains at the forefront of its mission, promising to drive further innovation in the hair care industry.